Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUI updates add a 'Show glossary' option and refresh QC-related metadata (Last Update Submitted that Met QC Criteria and Last Update Posted); the No FEAR Act Data label appears and the revision tag is updated to v3.4.0.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to trial details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedLocations section expanded to list numerous US states and Canadian provinces, with revision tag v3.3.3. The update reorganizes location data for the study.SummaryDifference2%

- Check69 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. No substantive study details or page functionality are affected.SummaryDifference0.0%

- Check76 days agoChange DetectedListed site updated from University of Florida Health Science Center - Gainesville to UF Health Cancer Institute - Gainesville. Added Informed Consent Form PDFs for Part A (Safety Phase) and Part B (Efficacy Phase) with Revision: v3.3.1, and included a Last Update Posted (Estimated) timestamp.SummaryDifference0.5%

- Check84 days agoChange DetectedRemoved the government funding status notice banner from the page, which previously warned that information may not be up to date due to appropriations and directed users to the opm.gov status page.SummaryDifference0.2%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.